IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

PFM Health Sciences, LP

Q4 2019 Holdings

Filed 2020-02-14 | 61 holdings | $201.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↑Shares% Portfolio
Audentes Therapeutics Inc(BOLDEUR)COM05070R104$73.8K1,232,8730.0%
Gilead Sciences Inc(GILD)COM375558103$87.8K1,351,7360.0%
Cigna Corp New(CI)CallCOM125523100$106.2K519,5000.1%
Alexion Pharmaceuticals Inc(ALXN)COM015351109$116.4K1,076,4420.1%
Gilead Sciences Inc(GILD)CallCOM375558103$196.5K3,024,2000.1%
Alibaba Group Hldg LTD(BABA)SPONSORED ADS01609W102$9.4M44,4114.7%
Coherus Biosciences Inc(CHRS)COM19249H103$9.6M535,0864.8%
Abbvie Inc(ABBV)COM00287Y109$14.7M166,2397.3%
Biomarin Pharmaceutical Inc(BMRN)COM09061G101$46.8M553,63423.2%
Centene Corp del(CNC)COM15135B101$51.5M819,22925.5%
Biogen Inc(BIIB)COM09062X103$67.8M228,32833.6%
PreviousPage 2 of 2